Comments on: The clinical relevance of various methods of classifying ipsilateral breast tumor recurrence as either true local recurrence or new primary

Breast Cancer Res Treat. 2023 Jan;197(1):243-244. doi: 10.1007/s10549-022-06784-0. Epub 2022 Oct 30.

Fei-Lin Qu^{1

2}, Jun-Jie Li^{1

2}, Zhi-Ming Shao^{3

4}

¹ Department of Breast Surgery, Fudan University Shanghai Cancer Center, No. 270 Dong-An Road, Xuhui District, Shanghai, 200032, People's Republic of China.
² Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
³ Department of Breast Surgery, Fudan University Shanghai Cancer Center, No. 270 Dong-An Road, Xuhui District, Shanghai, 200032, People's Republic of China. [email protected].
⁴ Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Shanghai, 200032, China. [email protected].

No abstract available

Publication types